Pulmonx Corp Stock Today
| LUNG Stock | USD 6.79 0.37 5.76% |
Performance0 of 100
| Odds Of DistressOver 60
|
Pulmonx Corp is trading at 6.79 as of the 25th of November 2024. This is a 5.76% increase since the beginning of the trading day. The stock's lowest day price was 6.25. Pulmonx Corp has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Pulmonx Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 1st of October 2020 | Category Healthcare | Classification Health Care |
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 39.49 M outstanding shares of which 986.14 K shares are now shorted by private and institutional investors with about 4.92 trading days to cover. More on Pulmonx Corp
Moving against Pulmonx Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pulmonx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Steven Williamson | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPulmonx Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pulmonx Corp's financial leverage. It provides some insight into what part of Pulmonx Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pulmonx Corp (LUNG) is traded on NASDAQ Exchange in USA. It is located in 700 Chesapeake Drive, Redwood City, CA, United States, 94063 and employs 279 people. Pulmonx Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 268.12 M. Pulmonx Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 39.49 M outstanding shares of which 986.14 K shares are now shorted by private and institutional investors with about 4.92 trading days to cover.
Pulmonx Corp currently holds about 162.09 M in cash with (37.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35.
Check Pulmonx Corp Probability Of Bankruptcy
Ownership AllocationPulmonx Corp owns a total of 39.49 Million outstanding shares. The majority of Pulmonx Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pulmonx Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pulmonx Corp. Please pay attention to any change in the institutional holdings of Pulmonx Corp as this could imply that something significant has changed or is about to change at the company. Also note that almost twenty-four thousand eighty-eight invesors are currently shorting Pulmonx Corp expressing very little confidence in its future performance.
Check Pulmonx Ownership Details
Pulmonx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Franklin Resources Inc | 2024-09-30 | 700.4 K | |
| Rock Springs Capital Management Lp | 2024-06-30 | 652.4 K | |
| Pura Vida Investments, Llc | 2024-09-30 | 509.8 K | |
| Altium Capital Management, Lp | 2024-09-30 | 500 K | |
| Millennium Management Llc | 2024-06-30 | 448.6 K | |
| Partner Fund Management Lp | 2024-09-30 | 368.9 K | |
| Northern Trust Corp | 2024-09-30 | 362.2 K | |
| D. E. Shaw & Co Lp | 2024-09-30 | 360.8 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 347.5 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 6.9 M | |
| Fmr Inc | 2024-09-30 | 5.9 M |
Pulmonx Corp Historical Income Statement
Pulmonx Stock Against Markets
Pulmonx Corp Corporate Management
| David Lehman | General Secretary | Profile | |
| Geoffrey Rose | Chief Officer | Profile | |
| Lauren Cristina | VP Adm | Profile | |
| John McKune | VP Controller | Profile | |
| Sri Radhakrishnan | Chief Officer | Profile | |
| Mehul Joshi | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.